Vizora日本語

OlympusOLYMPUS CORPORATION7733東証プライム精密機器FY ending Mar 2026, consolidated, IFRS

Olympus FY ending Mar 2026 results

About 69% of Olympus's sales come from Gastrointestinal Solutions, with Surgical and Interventional Solutions and Other making up much of the rest.

Out of every ¥100 of sales, about ¥10 is left as operating profit.

Revenue changed +1.3% from the prior year, operating profit -40.2%.

Revenue and profit pattern

Revenue up, profit downRevenue grew faster

Revenue +1.3% · profit -40.2%, calculated from disclosed figures.

Operating leverage: -30.06× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2025 → FY ending Mar 2026

Revenue
+1.3%¥997.3B → ¥1.01T
Gross profit
-4.3%¥683.7B → ¥654.1B
Operating income
-40.2%¥162.5B → ¥97.1B
Net income attributable to owners
-42.2%¥117.9B → ¥68.2B
Operating cash flow
-47.2%¥190.5B → ¥100.6B
Free cash flow
-85.5%¥125.3B → ¥18.2B

Results at a glance

  • Revenue for the FY ending Mar 2026 came in at ¥1.01T, up +1.3% from ¥997.3B the year before, so sales barely moved.
  • Profit dropped sharply. Operating income went from ¥162.5B to ¥97.1B (-40.2%), and net income attributable to owners from ¥117.9B to ¥68.2B (-42.2%).
  • Operating cash flow fell -47.2% to ¥100.6B, and free cash flow shrank to ¥18.2B, down -85.5%.

What drove the change

  • US tariffs and a shift toward lower-margin products pushed the cost of sales up relative to revenue
  • The company booked costs for a global reorganization of roles, plus impairment losses on development and other intangible assets
  • Its investment in Swan EndoSurgical, a joint venture developing robotic endoscopy products, added expenses
  • Surgical and Interventional Solutions swung to an operating loss, hit by shipment holds and a voluntary recall on some products and by lower sales in China and Japan. Gastrointestinal Solutions still grew, led by Europe and Asia-Pacific

Things to watch

  • If fixes for the FDA warning letters fall behind, further regulatory action could disrupt supply. An import alert already blocks some devices made at Aizu Olympus from entering the US
  • Shifting tariffs and policies favoring local suppliers, such as in China, could squeeze profitability
  • Shortages of key parts, including semiconductors, could delay production and product supply

Annual securities report, 158th fiscal period (Apr 2025 - Mar 2026) / Management's analysis of financial position, operating results and cash flows · Annual securities report, 158th fiscal period (Apr 2025 - Mar 2026) / Business risks

Where the money goes

FY ending Mar 2025 → FY ending Mar 2026

Where ¥100 of sales goes

For every ¥100 Olympus sells, how much goes where, and how much is kept.

FY ending Mar 2026
Cost of sales
¥35
SG&A
¥50
Other costs
¥5
Operating profit
¥10
Net profit kept
¥7

Annual margin trends

Gross margin64.7%
FY ending Mar 2021: 62.9%62.9%FY ending Mar 2022: 67.5%67.5%FY ending Mar 2023: 67.7%67.7%FY ending Mar 2025: 68.6%68.6%FY ending Mar 2026: 64.7%64.7%FY21FY22FY23FY24FY25FY26
Operating margin9.6%
FY ending Mar 2021: 11.2%11.2%FY ending Mar 2022: 19.5%19.5%FY ending Mar 2023: 21.2%21.2%FY ending Mar 2025: 16.3%16.3%FY ending Mar 2026: 9.6%9.6%FY21FY22FY23FY24FY25FY26
Net margin6.7%
FY ending Mar 2021: 1.8%1.8%FY ending Mar 2022: 15.4%15.4%FY ending Mar 2023: 16.3%16.3%FY ending Mar 2024: 26.2%26.2%FY ending Mar 2025: 11.8%11.8%FY ending Mar 2026: 6.7%6.7%FY21FY22FY23FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2026

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第158期(2025/04/01－2026/03/31)

    ID S100YDN32026-06-18Open

  • EDINET (FSA Japan)

    有価証券報告書－第157期(2024/04/01－2025/03/31)

    ID S100W0092025-06-19Open

  • EDINET (FSA Japan)

    有価証券報告書－第156期(2023/04/01－2024/03/31)

    ID S100TNZ42024-06-20Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第155期(2022/04/01－2023/03/31)

    ID S100RV9X2023-09-19Open

  • EDINET (FSA Japan)

    有価証券報告書－第154期(令和3年4月1日－令和4年3月31日)

    ID S100OBAY2022-06-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第153期(令和2年4月1日－令和3年3月31日)

    ID S100LL9I2021-06-21Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image